CTNM
CTNM
NASDAQ · Pharmaceuticals

Contineum Therapeutics Inc-A

$11.94
-0.22 (-1.81%)
As of Jun 21, 10:19 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 11 85%
Hold 2 15%
Sell 0 0%
Price Target
Analyst Price Target +225.1% upside
Low Target $27.95
Average Target $38.82
High Target $46.43
Current Price $11.94
Current
$11.94
Target
$38.82
$27.95 $38.82 avg $46.43
Scenario Analysis
Bear Case
$27.95
134.1%
Low target
Base Case
$38.82
+225.1%
Avg target
Bull Case
$46.43
+288.9%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$16.33
-26.9% from high
52-Week Low
$3.57
+234.5% from low
Target vs 52W High
$38.82
+137.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%